Your opinion matters. We've officially kicked off our third annual Healthcare Dive reader survey and we want to hear from you.
The feedback you provide will directly inform the journalism you see in the newsletter and on our site. The survey should take about five minutes to complete and will help us serve you better. Plus, all respondents will be entered to win a $200 gift card of your choice.
Take the survey
If you've already completed the survey, thank you. We look forward to reviewing your responses.
Thanks again for reading, supporting, and trusting our publications. Sean Griffey CEO Industry Dive Twitter | Email After protests from providers and medical societies, the biggest private payer is delaying the start of the policy until at least the end of the COVID-19 national emergency. But hospitals say it should be scrapped for good. | AHA sent a letter asking the nation's largest commercial insurer to abandon a policy that denies ER visits if they are later deemed unnecessary. The policy will lead to a chilling effect on members seeking ER care, the group said. | The tech giant also announced more in-app information about lab tests without having to run an Internet search, and hearing assistance, a mobility feature and a respiratory tracker on its devices. | Meet the AI helping industry leaders automate the provider experience. | The acquisition by the Google-backed primary care chain aligns two players in the value-based care movement, which eschews traditional payer-provider arrangements in favor of a concierge membership model. | A ruling on the fate of the landmark law could come as early as Thursday morning. | With its multibillion-dollar acquisition of value-based Iora, One Medical is betting big on capturing longitudinal care and the profitability of risk. | Recommended For You Improve your recommendations: click here to update your profile. Deep Dive With the decision, the agency cleared the way for what many predict will become a lucrative and highly sought-after option — though fierce debate continues over whether Biogen's aducanumab actually benefits patients. | Featured Resources FROM: Consensus | Learn how to fast-track your digital interoperability | | From Our Library Webinar - on demand Progeny Health | Webinar - on demand Tipalti | View all resources Best of What We're Reading The Washington Post | CBS News | Wall Street Journal | Kaiser Health News | Bloomberg Law | Wall Street Journal | Upcoming Events June 15, 2021 - June 15, 2021 | Webinar 2pm ET | July 15, 2021 - July 15, 2021 | Webinar 2pm ET | Dive Into a Topic |
0 Comments